EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Effects of Chaihu-Shugan-San as an adjunctive intervention on psychosocial adaptation and meaning in life in patients with hepatocellular carcinoma comorbid with depression: a randomized controlled trial

Yiyuan Deng

Psycho-Oncologie · 11.08.2026 · 20 (7)

DOI: 10.18282/po5719 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Psycho-Oncologie, online erschienen am 11.08.2026. Verfasst von Yiyuan Deng. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to evaluate the efficacy of Chaihu-Shugan-San (CHSGS), a classic Chinese herbal formula, as an adjunctive intervention on psychosocial adaptation and meaning in life in patients with hepatocellular carcinoma (HCC) comorbid with depression, and to preliminarily explore its potential mechanisms.

Methods

A randomized, double-blind, placebo-controlled trial was conducted. A total of 132 eligible HCC patients (BCLC stage A/B) with comorbid moderate-to-severe depression (HAMD-17 score ≥ 17) were randomly assigned to either the combination group (conventional antitumor therapy plus CHSGS granule) or the control group (conventional antitumor therapy plus placebo) for a 12-week intervention. The primary outcomes were the total scores of the Chinese versions of the Psychosocial Adjustment to Illness Scale (PAIS-SR) and the Meaning in Life Presence Scale (MIPS). Secondary outcomes included the Hamilton Depression Rating Scale (HAMD-17) score, the Functional Assessment of Cancer Therapy-Hepatobiliary (FACT-Hep) score, and serum levels of inflammatory cytokines (IL-6 and TNF-α). Assessments were performed at baseline, week 6, week 12 (end of intervention), and at a 4-week follow-up.

Results

A total of 123 patients completed the study. Repeated-measures analysis of variance revealed significant interaction effects between time and group on both psychosocial adaptation and meaning in life. Compared to the control group, the combination group demonstrated significantly higher PAIS-SR and MIPS scores at week 12 and at follow-up. Furthermore, the combination group showed significantly greater improvements in depressive symptoms and quality of life, as well as greater reductions in serum IL-6 and TNF-α levels than the control group. Correlation analysis indicated that the improvement in psychosocial adaptation was negatively correlated with the decrease in IL-6, and the enhancement of meaning in life was negatively correlated with the decrease in TNF-α.

Conclusion

Adjuvant use of Chaihu-Shugan-San alongside conventional antitumor therapy effectively improves psychosocial adaptation and meaning in life, alleviates depressive symptoms, and enhances quality of life in HCC patients with depression. Its effects may be associated with the modulation of inflammatory responses. This formula provides a beneficial Traditional Chinese Medicine option for the integrated mind-body care of HCC patients.

Zitieren

APA

Deng, Y. (2026). Effects of Chaihu-Shugan-San as an adjunctive intervention on psychosocial adaptation and meaning in life in patients with hepatocellular carcinoma comorbid with depression: a randomized controlled trial. Psycho-Oncologie, 20(7). https://doi.org/10.18282/po5719

Vancouver

Deng Y. Effects of Chaihu-Shugan-San as an adjunctive intervention on psychosocial adaptation and meaning in life in patients with hepatocellular carcinoma comorbid with depression: a randomized controlled trial. Psycho-Oncologie. 2026;20(7). doi:10.18282/po5719

BibTeX
@article{Deng2026,
  author = {Deng, Yiyuan},
  title = {Effects of Chaihu-Shugan-San as an adjunctive intervention on psychosocial adaptation and meaning in life in patients with hepatocellular carcinoma comorbid with depression: a randomized controlled trial},
  journal = {Psycho-Oncologie},
  year = {2026},
  volume = {20},
  number = {7},
  doi = {10.18282/po5719}
}
Kostenlos starten →